123 related articles for article (PubMed ID: 30316100)
1. Targeted metabolomics to understand the association between arsenic metabolism and diabetes-related outcomes: Preliminary evidence from the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Umans JG; Yracheta J; Best LG; Francesconi K; Goessler W; Bottiglieri T; Gamble MV; Cole SA; Zhao J; Navas-Acien A
Environ Res; 2019 Jan; 168():146-157. PubMed ID: 30316100
[TBL] [Abstract][Full Text] [Related]
2. Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Umans JG; Yracheta J; Best LG; Francesconi K; Goessler W; Balakrishnan P; Cole SA; Gamble MV; Howard BV; Navas-Acien A
Environ Int; 2018 Dec; 121(Pt 1):728-740. PubMed ID: 30321848
[TBL] [Abstract][Full Text] [Related]
3. Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study.
Kuo CC; Howard BV; Umans JG; Gribble MO; Best LG; Francesconi KA; Goessler W; Lee E; Guallar E; Navas-Acien A
Diabetes Care; 2015 Apr; 38(4):620-7. PubMed ID: 25583752
[TBL] [Abstract][Full Text] [Related]
4. Association of Low-Moderate Arsenic Exposure and Arsenic Metabolism with Incident Diabetes and Insulin Resistance in the Strong Heart Family Study.
Grau-Perez M; Kuo CC; Gribble MO; Balakrishnan P; Jones Spratlen M; Vaidya D; Francesconi KA; Goessler W; Guallar E; Silbergeld EK; Umans JG; Best LG; Lee ET; Howard BV; Cole SA; Navas-Acien A
Environ Health Perspect; 2017 Dec; 125(12):127004. PubMed ID: 29373862
[TBL] [Abstract][Full Text] [Related]
5. Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.
Gribble MO; Crainiceanu CM; Howard BV; Umans JG; Francesconi KA; Goessler W; Zhang Y; Silbergeld EK; Guallar E; Navas-Acien A
Environ Health; 2013 Dec; 12():107. PubMed ID: 24321145
[TBL] [Abstract][Full Text] [Related]
6. An atlas of metallome and metabolome interactions and associations with incident diabetes in the Strong Heart Family Study.
Sanchez TR; Hu X; Zhao J; Tran V; Loiacono N; Go YM; Goessler W; Cole S; Umans J; Jones DP; Navas-Acien A; Uppal K
Environ Int; 2021 Dec; 157():106810. PubMed ID: 34365318
[TBL] [Abstract][Full Text] [Related]
7. The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Best LG; Yracheta J; Lazo M; Vaidya D; Balakrishnan P; Gamble MV; Francesconi KA; Goessler W; Cole SA; Umans JG; Howard BV; Navas-Acien A
Am J Epidemiol; 2018 Aug; 187(8):1598-1612. PubMed ID: 29554222
[TBL] [Abstract][Full Text] [Related]
8. Associations between rice consumption, arsenic metabolism, and insulin resistance in adults without diabetes.
Li X; Wang X; Park SK
Int J Hyg Environ Health; 2021 Aug; 237():113834. PubMed ID: 34488179
[TBL] [Abstract][Full Text] [Related]
9. Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study.
Spratlen MJ; Gamble MV; Grau-Perez M; Kuo CC; Best LG; Yracheta J; Francesconi K; Goessler W; Mossavar-Rahmani Y; Hall M; Umans JG; Fretts A; Navas-Acien A
Food Chem Toxicol; 2017 Jul; 105():387-397. PubMed ID: 28479390
[TBL] [Abstract][Full Text] [Related]
10. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.
Navas-Acien A; Umans JG; Howard BV; Goessler W; Francesconi KA; Crainiceanu CM; Silbergeld EK; Guallar E
Environ Health Perspect; 2009 Sep; 117(9):1428-33. PubMed ID: 19750109
[TBL] [Abstract][Full Text] [Related]
11. Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.
Kaufman JA; Mattison C; Fretts AM; Umans JG; Cole SA; Voruganti VS; Goessler W; Best LG; Zhang Y; Tellez-Plaza M; Navas-Acien A; Gribble MO
Environ Res; 2021 Apr; 195():110864. PubMed ID: 33581093
[TBL] [Abstract][Full Text] [Related]
12. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.
Gribble MO; Howard BV; Umans JG; Shara NM; Francesconi KA; Goessler W; Crainiceanu CM; Silbergeld EK; Guallar E; Navas-Acien A
Am J Epidemiol; 2012 Nov; 176(10):865-74. PubMed ID: 23097256
[TBL] [Abstract][Full Text] [Related]
13. Association of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS).
Balakrishnan P; Vaidya D; Franceschini N; Voruganti VS; Gribble MO; Haack K; Laston S; Umans JG; Francesconi KA; Goessler W; North KE; Lee E; Yracheta J; Best LG; MacCluer JW; Kent J; Cole SA; Navas-Acien A
Environ Health Perspect; 2017 Jan; 125(1):15-22. PubMed ID: 27352405
[TBL] [Abstract][Full Text] [Related]
14. The association of arsenic exposure and arsenic metabolism with all-cause, cardiovascular and cancer mortality in the Strong Heart Study.
Kuo CC; Balakrishnan P; Gribble MO; Best LG; Goessler W; Umans JG; Navas-Acien A
Environ Int; 2022 Jan; 159():107029. PubMed ID: 34890900
[TBL] [Abstract][Full Text] [Related]
15. Nutrition, one-carbon metabolism and arsenic methylation in Bangladeshi adolescents.
Saxena R; Liu X; Navas-Acien A; Parvez F; LoIacono NJ; Islam T; Uddin MN; Ilievski V; Slavkovich V; Balac O; Graziano JH; Gamble MV
Environ Res; 2021 Apr; 195():110750. PubMed ID: 33476663
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study.
Lee ET; Howard BV; Savage PJ; Cowan LD; Fabsitz RR; Oopik AJ; Yeh J; Go O; Robbins DC; Welty TK
Diabetes Care; 1995 May; 18(5):599-610. PubMed ID: 8585996
[TBL] [Abstract][Full Text] [Related]
17. Associations of maternal arsenic exposure with adult fasting glucose and insulin resistance in the Strong Heart Study and Strong Heart Family Study.
Tinkelman NE; Spratlen MJ; Domingo-Relloso A; Tellez-Plaza M; Grau-Perez M; Francesconi KA; Goessler W; Howard BV; MacCluer J; North KE; Umans JG; Factor-Litvak P; Cole SA; Navas-Acien A
Environ Int; 2020 Apr; 137():105531. PubMed ID: 32059145
[TBL] [Abstract][Full Text] [Related]
18. The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence.
Kuo CC; Moon KA; Wang SL; Silbergeld E; Navas-Acien A
Environ Health Perspect; 2017 Aug; 125(8):087001. PubMed ID: 28796632
[TBL] [Abstract][Full Text] [Related]
19. The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.
Zheng LY; Umans JG; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Bandeen-Roche K; Guallar E; Howard BV; Weaver VM; Navas-Acien A
Epidemiology; 2015 Jul; 26(4):601-12. PubMed ID: 25929811
[TBL] [Abstract][Full Text] [Related]
20. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.
Moon KA; Guallar E; Umans JG; Devereux RB; Best LG; Francesconi KA; Goessler W; Pollak J; Silbergeld EK; Howard BV; Navas-Acien A
Ann Intern Med; 2013 Nov; 159(10):649-59. PubMed ID: 24061511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
